Introduction: One of the biggest challenges for HIV-infected adolescents on antiretroviral therapy (ART) is the long-term maintenance of viral suppression, which is the third 90% goal of UNAIDS. Therapeutic Education (TE), process of acquiring abilities and skills that help the patient to live optimally with his illness is one of the strategies that contribute to the achievement of viral suppression through the therapeutic adhesion contract and the follow-up of the patient. The aim of this study was to evaluate the impact of TE on the virologic response of children and adolescents aged 8 - 19 under ART and followed up at the Laquintinie Hospital of Douala (LHD). Method: A cross-sectional study was conducted at the Pediatric Unit of the HIV/AIDS Accredited Treatment Center (ATC) at LHD from February to May 2016. Children and adolescents aged 8 to 19 years on ART, followed in ATC/LHD whose parents had agreed to participate in the study, and who had achieved at least one viral load before and after initiation of TE, were recruited consecutively during routine medical follow-up. Data were collected from patients’ medical records and questionnaires administered to study participants. Results: A total of 198 children and adolescents were included in this study with an average age of 14 years ( ±3). In this study population, 86.1% of children aged 8 - 10 years had acquired knowledge of the importance of taking medications, 95.4% and 97.3% of adolescents aged 11 - 14 years and 15 - 19 years had knowledge of medication schedules respectively. Among children and adolescents with undetectable viral load prior to initiation of TE, 76.5% maintained an undetectable viral load after initiation of TE. In addition, 72.3% of those whose viral load was detectable before initiation of TE had acquired an undetectable or decreasing viral load after initiation of TE. The only exposure factor significantly associated with maintaining undetectable viral load after initiation of TE was having less than 10 TE sessions ( p = 0.02). Conclusion: The virologic response appears to be better in subjects who acquire skills faster through TE and therefore require fewer learning sessions to adapt. In addition, TE effectively contributes to achieving the third 90% goal of UNAIDS.
Cameroon has adhered to the strategic Objectives 90-90-90 of United Nations Program on HIV/AIDS (UNAIDS) [
Since 2011, “the therapeutic school” has been set up at the Accredited HIV/ AIDS Treatment Center (ATC) of LHD to transmit therapeutic self-management skills to children and adolescents on ART. The aim of this study was to evaluate the impact of TE on the virologic response of children and adolescents aged 8 - 19 under ART and monitored at the ATC/LHD.
A cross-sectional study was conducted at the pediatric unit of the ATC/LHD during the period from February to May 2016 (4 months). It is a center of excellence for pediatric HIV care covering an active line of 452 children and adolescents at the time of the study.
Children and adolescents aged 8 to 19 on ART, followed at ATC/LHD whose parents accepted the study and had at least one viral load before and after the start of participation in the study. Therapeutic School were recruited consecutively during routine medical consultations.
Therapeutic classes have been in place at ATC/LHD since March 2011 to improve the disclosure of HIV status, viral load control and the quality of life of HIV infected children and adolescents. They include individual interviews on one hand and group meetings on the other hand for children and adolescents aged 8 to 19 (organized into three age groups (8 - 10, 11 - 14 and 15 - 19 years). They are facilitated by a multidisciplinary team of trained health care providers (educators, psychologists, nurses, doctors). The content of the therapeutic classes is adapted to the age group as follows: 1) from the 8 - 10 age group: destructive action of the virus (unnamed virus) in the body, the importance of taking the drug, the effect of falling asleep by the drug and the means of transmitting the virus; 2) from 11 - 14 years of age: destructive action of the virus (virus named) in the body, the importance of taking the drug at the given times, management of the secrecy related to HIV status in those who already benefited from the full disclosure of HIV status; 3) from the 15 - 19 age group: interpretation of CD4 count and viral load.
Data were collected from patients’ medical records and questionnaires administered to study participants. Data collected from patients’ medical records included sociodemographic characteristics, clinical and laboratory characteristics (viral load) before and after initiation of TE sessions, and HIV status announcement level of study participants. Questionnaires were used to describe the type (individual interview or group meeting) and the number of TE sessions received by participants, and to categorize the skills acquired by the participants in the therapeutic classes considering the age group according to a “bad”, “average” or “good” scale.
The assessment of the scale of knowledge for the acquisition of the notions transmitted to the therapeutic education was defined according to the age based on a score graduated from 0 to 10.
Was considered as patient with a good knowledge, patients who obtained:
・ a score of 8 to 10 for children aged 8 to 10;
・ a score of 11 to 15 for children aged 11 to 14;
・ a score of 16 and 20 for children aged 15 to 19.
For average knowledge:
・ a score of 5 to 7 for children aged 8 to 10;
・ a score of 7 to 10 for children aged 11 to 14;
・ a score of 11 and 15 for children aged 15 to 19.
For bad knowledge:
・ a score of 0 to 4 for children aged 8 to 10;
・ a score of 0 to 6 for children aged 11 to 14;
・ a score of 0 and 10 for children aged 15 to 19.
An informed consent form was provided to the parent or legal guardian of eligible children and teens for the study, as well as a consent form for adolescents over the age of 14 in the waiting room for consultations, medical or pharmaceutical, during the dispensing of drugs. For unaccompanied children and adolescents, an informed consent form was given to them to give to their parent or legal guardian. In addition, a telephone conversation was sometimes necessary to provide them with additional information for a better understanding of the study. After obtaining the parent’s consent and, if applicable, the adolescent’s consent, an age-appropriate assessment skills questionnaire was provided to the participant at a time. Monthly session of the therapeutic school or in the waiting room for medical consultations or during the dispensing of medicines from the pharmacy. The participant completed the questionnaire alone for a maximum of 15 minutes. At the same time, the other study data were collected in the participant’s medical record.
The main variable of interest was the change in viral load (VL), measured before and after the initiation of TE sessions, defined as a binary qualitative variable of modalities. VL detectable after initiation of the TE or VL undetectable after initiation of TE if the participant belonged to the group with an undetectable viral load prior to initiation of TE (group 1). It was defined by the terms “stationary or augmented VL after initiation of TE” or “regression or undetectable VL after initiation of TE” if the participant belonged to the group with a detectable viral load prior to initiation of TE (group 2).
The main explanatory variables included the type of TE (individual-only, or individual and collective) and the number of TE sessions administered (≤10 sessions or >10 sessions).
Secondary explanatory variables related to characteristics of the child or adolescent (age (≤14 years or >14 years), degree of HIV status announcement (partial or complete), level of education (illiterate/primary or secondary/superior)) and the caregiver of the child or adolescent (type of relationship with the child or adolescent (father/mother or guardian), HIV status (negative or positive)).
The descriptive analysis consisted in estimating the size of the categories of the qualitative variables and the average of the quantitative variables associated with the standard deviation.
The association between the explanatory variables and the evolution of the viral load in children or adolescents who initiated TE was studied by univariate and multivariate analyzes using logistic regression models. These analyses were performed separately in groups 1 (undetectable viral load before initiation of TE) and 2 (detectable viral load after initiation of TE). Odds ratios between the categories of exposure variables were compared using the Score test. The level of education, the degree of announcement of HIV status, the type and number of therapeutic education sessions administered were included in all multivariate models (a priori exposure factors). Other exposure variables, with a significance level (p) ≤ 0.20 in univariate analysis, were also included in the initial multivariate model. The final multivariate model, constructed by top-down explanatory variables, included a priori exposure factors and other exposure variables with p ≤ 0.20.
The collected data was captured on the SPSS software and analyzed using the Stata © 13.0 software (Stata Corp, College Station, TX). The threshold of significance was p ˂ 0.05.
This study was conducted in accordance with ethics regulations for research on humans in Cameroon. An ethical clearance was obtained from the Institutional review Board of the University of Douala prior to the start of the study (N˚/CEI-UDo/740/01/2017/T) and administrative authorization (N˚0010/AR/ MINSANTE/DHL/CM) was obtained from the LHD. Before enrolment and the administration of questionnaire, parents or legal guardians were informed on the purpose and process of the investigation (background, goals, methodology, study constraints, respect of privacy and data confidentiality, and rights to opt out from the study), and a signed informed assent was obtained from all parents or legal guardians for inclusion and use of anonymous data of their children in publication and conference presentations. Participation was voluntary, anonymous and without compensation.
A total of 198 children and adolescents were included in this study at an average age of 14 years (±3). The 8 - 10, 11 - 14 and 15 - 19 age groups accounted for 17.2%, 44.9% and 37.9% of the study population respectively (
At the time of this study, the knowledge of the importance of taking medicines was acquired by 86.1% of children 8 - 10 years and the effect of drowsiness of the virus by taking the drug by 75.0% (
Prior to initiation of TE, 133 (67.2%) children and adolescents in this study had an undetectable viral load (group 1) (
In group 1 (undetectable viral load prior to TE initiation), the only exposure factor significantly associated with maintaining undetectable viral load after initiation of TE in the univariate analysis was receiving less than 10 TE sessions (OR = 2.6 (1.1-5.9), p = 0.02) (
Feature | Total, n (%) N = 198 |
---|---|
Age, in years | |
8 - 10 | 34 (17.2) |
11 - 14 | 89 (44.9) |
15 - 19 | 75 (37.9) |
Mean ± standard deviation | 14 ± 3 |
Sex, | |
Male | 95 (48.0) |
Residence | |
Douala | 182 (91.9) |
Littoral region, out of Douala | 10 (5.1) |
Another region | 6 (3.0) |
HIV status disclosure | |
Complete | 111 (56.1) |
Partial | 87 (43.9) |
Level of education | |
Primary | 54 (27.3) |
Secondary | 138 (69.7) |
University | 3 (1.5) |
Illiterate | 3 (1.5) |
Vital status of parents | |
Father and mother alive | 75 (37.9) |
Orphan of mother | 29 (14.6) |
Orphan of father | 51 (25.8) |
Orphan of both parents | 43 (21.7) |
Person in charge of the child or adolescent’s care | |
Mother | 96 (48.5) |
Father | 23 (11.6) |
Guardian | 80 (39.9) |
HIV status of person in charge of the child or adolescent’s care | |
HIV− | 90 (45.5) |
HIV+ | 108 (54.5) |
Nature of the relationship between the child or adolescent and the guardian. if applicable | |
Uncle or Aunt | 52 (65.8) |
Grandparent | 21 (26.6) |
Step mother or step father | 3 (3.8) |
Brother or Sister | 2 (2.5) |
Institution | 1 (1.3) |
LHD: Laquintinie Hospital of Douala; n: Number of children or adolescents in the approved category of the variable; %: percentage; N: Total number of children/adolescents.
Nature of knowledge or skill | Age range | ||
---|---|---|---|
8 - 10 years, n (%) n = 34 | 11 - 14 years, n (%) n = 87 | 14 - 19 years, n (%) n = 75 | |
Destructive mechanism of virus on the child’s organism | 16 (45.7) | ||
Knowledge on the importance of taking medications | 31 (86.1) | ||
Effect of quarantine of virus by the drug | 27 (75.0) | 47 (54.0) | 51 (68.0) |
Knowledge on life treatment and chronic disease | 69 (79.3) | 70 (93.3) | |
Knowledge on name of the drug | 57 (65.5) | 62 (82.7) | |
Knowledge on time to take medication | 83 (95.4) | 73 (97.3) | |
Interpretation of viral load | 56 (74.7) | ||
Interpretation of CD4 cell count | 44 (58.7) |
TE: Therapeutic Education; LHD: Laquintinie Hospital of Douala; n: Number of children/adolescents in the approved category of variable; %: percentage; N: Total number of children/adolescents.
Factor | Evolution of viral load after initiation of therapeutic education | |||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
Detectable viral load after initiation of TE (Group 1) n = 32 n (%) | Undetectable viral load after initiation of TE (Group 2) n = 101 n (%) | OR (95% CI) | p | Ajusted OR (95% CI) | p | |
Type of TE | ||||||
Individual | 14 (43.8) | 39 (38.6) | 1 | 0.27 | ||
Individual and collective | 18 (56.2) | 62 (61.4) | 0.8 (0.4 - 1.8) | |||
Number of TEsessions | ||||||
≤10 | 11 (34.4) | 58 (52.4) | 1 | 0.02 | 1 | 0.03 |
>10 | 21 (65.6) | 43 (48.6) | 2.6 (1.1 - 5.9) | 3.1 (1.1 - 8.7) | ||
HIV status of the person in charge of child or adolescent care | ||||||
HIV+ | 13 (40.6) | 57 (56.4) | 1 | 0.12 | ||
HIV− | 19 (59.4) | 44 (43.6) | 1.9 (0.8 - 4.3) | |||
Type of person in charge of child or adolescent care | ||||||
Father or mother | 16 (50.0) | 65 (64.4) | 1 | 0.15 | 1 | 0.07 |
Guardian | 16 (50.0) | 36 (35.6) | 1.8 (0.8 - 4.0) | 2.2 (0.9 - 5.2) | ||
Age of child or adolescent | ||||||
≤14 years | 18 (63.2) | 66 (65.4) | 1 | 0.35 | ||
>14 years | 14 (36.8) | 35 (34.6) | 1.5 (0.7 - 3.3) | |||
Level of education | ||||||
Secondary or higher | 23 (71.9) | 75 (74.3) | 1 | 0.79 | 1 | 0.26 |
Illiterate or primary | 9 (28.1) | 26 (25.7) | 1.1 (0.5 - 2.8) | 1.9 (0.6 - 6.1) | ||
---|---|---|---|---|---|---|
HIV disclosure status | ||||||
Partial | 10 (31.3) | 48 (47.5) | 1 | 0.11 | 1 | 0.18 |
Complete | 22 (68.7) | 53 (52.5) | 2.0 (0.9 - 4.6) | 2.2 (0.7 - 6.7) |
TE: Therapeutic Education, LHD: Laquintinie Hospital of Douala; Group 1: Children and adolescents with undetectable viral load before TE; Group 2: Children and adolescents with detectable viral load before TE; VL: Viral load; n: Number of children or adolescents belong to the category considered of the variable; %: percentage; N: Total number of children or adolescents; OR: Odds Ratio; 95% CI: 95% Confidence Interval; p: Chi-2 test.
Factor | Evolution of viral load after initiation of TE | |||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
VL stationary or increased after initiation of TE n = 18 n (%) | VL declining or undetectable after initiation of TE n = 47 n (%) | Crude OR (95% CI) | p | Ajusted OR (95% CI) | p | |
Type of TE | ||||||
Individual only | 4 (22.2) | 12 (25.5) | 1 | 0.78 | 1 | 0.66 |
Individual and collective | 14 (77.8) | 35 (74.5) | 1.2 (0.3 - 4.3) | 1.4 (0.3 - 5.6) | ||
Number of TE sessions | ||||||
≤10 | 7 (38.9) | 26 (55.3) | 1 | 0.24 | 1 | 0.26 |
>10 | 11 (61.1) | 21 (44.7) | 2.0 (0.6 - 6.0) | 2.0 (0.6 - 6.8) | ||
HIV status of person in charge of care | ||||||
HIV+ | 13 (72.2) | 25 (53.2) | 1 | 0.17 | ||
HIV− | 5 (27.8) | 22 (46.8) | 0.4 (0.1 - 1.4) | |||
Type of person in charge of adolescent or child care | ||||||
Father or mother | 14 (77.8) | 26 (59.6) | 1 | 0.17 | 1 | 0.12 |
Guardian | 4 (22.2) | 19 (40.4) | 0.4 (0.1 - 1.7) | 0.3 (1.0 - 1.3) | ||
Age of child or adolescent | ||||||
≤14 years | 9 (50.0) | 30 (63.8) | 1 | 0.31 | ||
>14 years | 9 (50.0) | 17 (36.2) | 1.8 (0.6 - 5.3) | |||
Level of education | ||||||
Secondary or higher | 13 (72.2) | 25 (53.2) | 1 | 0.17 | 1 | 0.98 |
Illiterate or primary | 5 (27.8) | 22 (46.8) | 0.4 (0.1 - 1.4) | 1.0 (0.2 - 5.5) | ||
HIV disclosure status | ||||||
Partial | 7 (38.9) | 22 (46.8) | 1 | 0.57 | 1 | 0.85 |
Complete | 11 (61.1) | 25 (53.2) | 1.4 (0.5 - 4.2) | 1.2 (0.2 - 5.9) |
TE: Therapeutic Education; LHD: Laquintinie Hospital of Douala; Group 1: Children and adolescents with undetectable viral load before TE; Group 2: Children and adolescents with detectable viral load before TE; VL: Viral load; n: Number of children or adolescents belong to the category considered of the variable; %: percentage; N: Total number of children or adolescents; OR: Odds Ratio; 95% CI: 95% Confidence Interval; p: Chi-2 test.
10 sessions of TE remained significantly associated with maintaining an undetectable viral load after initiation of TE (OR = 3.1 (1.1 - 8.7), p = 0.03) while a non-significant association was noted in children and adolescents living with their father or mother (OR = 2.2 (0.9 - 5.2), p = 0.07). There was no association between the maintenance of an undetectable viral load after initiation of TE and the HIV status of the person in charge of child or adolescent care, the type of TE administered, the level of education, the degree of announcement of HIV status and the age of the child or adolescent.
In group 2 (detectable viral load prior to TE initiation), no exposure factor was associated with changes in viral load after initiation of TE (
This study evaluated the impact of therapeutic education on the virologic response in 198 children and adolescents aged 8 to 19 years on ART and monitored at LHD. In this study population, 86.1% of children aged 8 - 10 years had acquired knowledge of the importance of taking medications, 95.4% and 97.3% of adolescents in the 11 - 14-year-old and 15 - 19-year-old age groups respectively had knowledge of medication schedules. These results are comparable to those of another study conducted among Cameroonian children [
The only exposure factor significantly associated with maintaining undetectable viral load after initiation of TE was having less than 10 TE sessions. This result seems to reflect a better virologic response in subjects who acquire skills faster through TE and therefore require fewer learning sessions to adapt. In addition, the nonsignificant association between maintaining undetectable viral load and living with his father or mother may be due to a lack of power in our study. A larger population of children with undetectable viral loads prior to TE initiation would result in a statistically significant association. In a Ugandan study [
In our study, the degree of disclosure was not associated with changes in viral load, contrasting with a Romanian study [
The lack of association between undetectable viral load after initiation of TE and different risk factors in the group of children and adolescents with detectable viral load prior to initiation of TE could be explained by a lack of statistical power. Indeed, the size of this group (N = 65) was relatively small.
The level of acquisition of skills and knowledge through TE was satisfactory among children and adolescents on antiretroviral therapy in this study. In addition, the TE had a favorable influence on maintaining or achieving undetectable viral load. As a result, TE effectively contributes to achieving the third 90% goal of UNAIDS and to improving pediatric HIV care in Cameroon.
・ CIP, ACZKB, SCB, OKN and LRN concepted and designed the study.
・ CIP, LAB, CO, FAN, GDN and CEEM collected, analyzed and interpreted the data.
・ CIP, GDN, FAN drafted the manuscript.
・ All authors approved of the final version.
We are very grateful to the children and adolescents and their families who have agreed to participate in this study. We express our gratitude to the ATC/LHD management team and its educators for their dedication and to the CBCHB and EPPAF partners in pediatric HIV care.
The authors declare that they have no competing interests.
Penda, C.I., Bissek, A.-C.Z.-K., Bilong, S.C., Boupda, L.-A., Okala, C., Ndongo, F.A., Ngondi, G.D., Eboumbou, E.C.M., Njock, L.R. and Ndombo, O.K. (2019) Impact of Therapeutic Education on the Viral Load of HIV Infected Children and Adolescents on Antiretroviral Therapy at the Douala Laquintinie Hospital, Cameroon. International Journal of Clinical Medicine, 10, 109-121. https://doi.org/10.4236/ijcm.2019.103011
AIDS: Acquired Immunodeficiency Syndrome;
ART: Antiretroviral Therapy;
ATC: Accredited Treatment Centre;
LHD: Laquintinie Hospital of Douala;
TE: Therapeutic Education;
RLS: Resource-Limited Settings;
UNAIDS: Joint United Nations Program on HIV/AIDS;
VL: Viral Load;
WHO: World Health Organization.